Zhuo Lin, Kong Yunxin, Chen Siting, Ma Yue, Cai Ting, Pan Jianqiang, Wang Xiuying, Gao Yihuan, Lu Hang, Li Xinyue, Zhao Hongying, Mackay Louisa, Dong Wendi, Zhuo Lang, Dong Dong
School of Public Health, Xuzhou Medical University, Xuzhou, China.
Department of Endocrinology, Peking University People's Hospital, Beijing, China.
Front Oncol. 2023 Jul 4;13:1156237. doi: 10.3389/fonc.2023.1156237. eCollection 2023.
Colorectal cancer is the third most common cancer worldwide. Colonoscopy is the gold standard for colorectal cancer screening. However, the colonoscopy participation rate in China is much lower than that in Europe and the United States. As only non-sedated colonoscopies are offered in colorectal cancer screening programs in China, the absence of sedation may contribute to this gap.
To explore the effect of free and partially participant-paid sedated colonoscopy on improving colorectal screening participation, we conducted a cross-sectional study under the framework of the Cancer Screening Program in Urban China in Xuzhou from May 2017 to December 2020. The Quanshan district was set as the control group and provided free non-sedated colonoscopy, the Yunlong district was set as a partial cost coverage group and offered partially participant-paid sedated colonoscopy, and the Gulou district was set as the full cost coverage group and offered free sedation colonoscopies. Multivariate logistic regression was used for multivariate analysis of colonoscopy participation and colorectal lesion detection rates between the groups.
From May 2017 to May 2020, 81,358 participants were recruited and completed questionnaire, 7,868 subjects who met high-risk conditions for CRC were invited to undergo colonoscopy. The colonoscopy participation rates in the control group, partially cost coverage, and full cost coverage groups were 17.33% (594/3,428), 25.66% (542/2,112), and 34.41% (801/2,328), respectively. Subjects in the partial and full cost coverage groups had 1.66-fold (95% CI: 1.48-1.86) and 2.49-fold (95% CI: 2.23-2.76) increased rates compared with those in the control group. The adjusted PARs for the partially and the full cost coverage group was 9.08 (95% CI: 6.88-11.28) and 18.97 (95% CI: 16.51-21.42), respectively. The detection rates of CAN in the control, partial-cost coverage, and full-cost coverage groups were 3.54% (21/594), 2.95% (16/542), and 5.12% (41/801), respectively. There were no significant differences in the detection rates between the group. However, sedated colonoscopy increases costs.
Sedated colonoscopy increased colonoscopy participation rates in both the partial and full cost-covered groups. A partial cost coverage strategy may be a good way to increase colorectal cancer participation rates and quickly establish a colorectal cancer screening strategy in underfunded areas.
结直肠癌是全球第三大常见癌症。结肠镜检查是结直肠癌筛查的金标准。然而,中国的结肠镜检查参与率远低于欧美国家。由于中国的结直肠癌筛查项目仅提供非镇静结肠镜检查,缺乏镇静可能是造成这一差距的原因。
为探讨免费及部分参与者付费的镇静结肠镜检查对提高结直肠癌筛查参与率的效果,我们于2017年5月至2020年12月在中国徐州城市癌症筛查项目框架下进行了一项横断面研究。泉山区设为对照组,提供免费非镇静结肠镜检查;云龙区设为部分费用覆盖组,提供部分参与者付费的镇静结肠镜检查;鼓楼区设为全额费用覆盖组,提供免费镇静结肠镜检查。采用多因素logistic回归对各组结肠镜检查参与率和结直肠病变检出率进行多因素分析。
2017年5月至2020年5月,共招募81358名参与者并完成问卷调查,邀请7868名符合结直肠癌高危条件的受试者接受结肠镜检查。对照组、部分费用覆盖组和全额费用覆盖组的结肠镜检查参与率分别为17.33%(594/3428)、25.66%(542/2112)和34.41%(801/2328)。部分费用覆盖组和全额费用覆盖组的受试者参与率较对照组分别提高了1.66倍(95%CI:1.48 - 1.86)和2.49倍(95%CI:2.23 - 2.76)。部分费用覆盖组和全额费用覆盖组的调整后PAR分别为9.08(95%CI:6.88 - 11.28)和18.97(95%CI:16.51 - 21.42)。对照组、部分费用覆盖组和全额费用覆盖组的结直肠癌检出率分别为3.54%(21/594)、2.95%(16/542)和5.12%(41/801)。各组检出率之间无显著差异。然而,镇静结肠镜检查会增加费用。
镇静结肠镜检查提高了部分费用覆盖组和全额费用覆盖组的结肠镜检查参与率。部分费用覆盖策略可能是提高结直肠癌参与率以及在资金不足地区快速建立结直肠癌筛查策略的良好方式。